With new beginnings comes new hope. As we enter 2021, screening will begin for the our Phase 1/2 RESKUE trial – the first in-human gene therapy clinical trial for patients with Krabbe Disease. Learn more about the RESKUE trial here.
RESKUE Trial for Patients with Krabbe Disease